Group Telehealth Weight Management Visits for Adolescents With Obesity
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03508622|
Recruitment Status : Active, not recruiting
First Posted : April 26, 2018
Last Update Posted : June 16, 2022
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
|Condition or disease||Intervention/treatment||Phase|
|Obesity, Childhood||Behavioral: Telehealth group sessions Behavioral: Empower clinic||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||32 participants|
|Intervention Model:||Single Group Assignment|
|Intervention Model Description:||Pilot intervention using retrospective control group.|
|Masking:||None (Open Label)|
|Official Title:||Group Telehealth Weight Management Visits for Adolescents With Obesity|
|Actual Study Start Date :||January 1, 2018|
|Estimated Primary Completion Date :||September 30, 2022|
|Estimated Study Completion Date :||March 31, 2023|
This group will receive weight management treatment via 12 online group sessions, over 6 months. They will have Bluetooth-enabled scales that will allow them to transmit their weight data to the PI in between research visits. They will answer questionnaires and have research visits at baseline, 3 months, and 6 months.
Behavioral: Telehealth group sessions
Telehealth sessions will utilize an online meeting platform and will be conducted by RDs, PTs, psychologists, and MDs, to deliver weight management information/counseling, to group of 5-6 14-18 yos with obesity.
This retrospective control group received standard in-clinic individualized weight management with a multi-disciplinary group of providers, via 6 monthly clinic visits, over 6 months.
Behavioral: Empower clinic
Empower visits for the retrospective control group were multi-disciplinary in nature, occurred at CHLA outpatient clinic, and were intended to be monthly (though actual adherence to recommended attendance was variable). Teen and minimum of one family member were asked to attend monthly visits, as per our standard clinical care.
- Change in anthropometric and clinical data [ Time Frame: 6 months ]change in absolute body mass index
- Change in anthropometric and clinical data [ Time Frame: 6 months ]% of 95th percentile body mass index
- Change in anthropometric and clinical data [ Time Frame: 6 months ]Labs: Glycosylated Hemoglobin; Hb A1c %
- Change in anthropometric and clinical data [ Time Frame: 6 months ]Labs: Alanine Aminotransferase; ALT units/L
- Change in anthropometric and clinical data [ Time Frame: 6 months ]Labs: Triglycerides; mg/dL
- Change in anthropometric and clinical data [ Time Frame: 6 months ]Blood Pressure; (mm Hg)a
- Change in quality of life [ Time Frame: 6 months ]Quality of life measurements will be obtained will be obtained through "Youth Telehealth Pilot Study Survey" questionnaire.
- Self-efficacy [ Time Frame: 6 months ]Self-efficacy measurements will be obtained through will be obtained through "Youth Telehealth Pilot Study Survey" questionnaire.
- Satisfaction with care [ Time Frame: 6 months ]Satisfaction measurements will be obtained through "Satisfaction using Telehealth" questionnaire.
- Attendance/Retention [ Time Frame: 6 months ]Attendance, no-show and same-day reschedules will be tallied
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
|Ages Eligible for Study:||14 Years to 18 Years (Child, Adult)|
|Sexes Eligible for Study:||All|
|Accepts Healthy Volunteers:||No|
- class 2 or 3 obesity OR
- class 1 obesity plus a significant comorbidity, such as impaired glucose tolerance or type 2 diabetes mellitus, hypertension, hyperlipidemia, non-alcoholic fatty liver disease (NAFLD), polycystic ovarian syndrome (PCOS), or obstructive sleep apnea.
- significant intellectual or neurodevelopmental disability
- inability to stand on a scale independently without assistance or use of an assistive device
- non-English speaking
Given the shared nature of group appointments, participants should be at approximately the same developmental stage as their peers. Discussion topics may include stigma, body image, family dynamics, and school issues, and therefore a wide variance in age range or cognitive status could potentially diminish the effectiveness of the group sessions. Non-English speaking youth will be excluded due to limitations in translation services for such a small pilot project. English speaking adolescents with non-English speaking parents will be included.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03508622
|United States, California|
|Children's Hospital Los Angeles|
|Los Angeles, California, United States, 90027|
|Responsible Party:||claudia borzutzky, Clinical Associate Professor Pediatrics, Children's Hospital Los Angeles|
|Other Study ID Numbers:||
|First Posted:||April 26, 2018 Key Record Dates|
|Last Update Posted:||June 16, 2022|
|Last Verified:||June 2022|
|Individual Participant Data (IPD) Sharing Statement:|
|Plan to Share IPD:||No|
|Studies a U.S. FDA-regulated Drug Product:||No|
|Studies a U.S. FDA-regulated Device Product:||No|